Interleukin-23 receptor genetic polymorphisms and ankylosing spondylitis susceptibility: a meta-analysis.
Up to now, many publications have evaluated the correlation between IL-23R polymorphisms and ankylosing spondylitis with conflicting results. We perform this meta-analysis to collect all the relevant studies up to date to further clarify the association of IL-23R polymorphisms with AS. Relevant published data were retrieved through Medline, PubMed, Embase, Web of Science, CNKI, Chinese BioMedical Literature Database on disc, and the statistical analysis was conducted using Stata 11.0. (1) A total of 11 literatures, including 13 population samples, were studied. (2) The allele A frequency of rs11209032 was higher in the AS group than in the controls (A vs. G: OR = 1.173, 95% CI = 1.107-1.243, P < 0.001). (3) The allele A of rs1004819 was higher in the AS group than in the controls in both all-pooled population (A vs. G: OR = 1.147, 95% CI = 1.022-1.287, P = 0.02) and Europe-pooled population (A vs. G: OR = 1.199, 95% CI = 1.007-1.429, P = 0.042). (4) The allele frequency T of rs1343151, G of rs10489629, and A of rs11209026 was lower in the AS group than in the controls. (5) No significant differences were found in allele frequency of rs10889677 polymorphism between cases and controls by random effects model. We concluded that the genetic susceptibility for AS is associated with the IL-23R gene polymorphisms. The protective SNPs include rs1343151, rs10489629, and rs11209026 while rs1004819 and rs11209032 may be the susceptibility SNPs.
Department of Epidemiology and Biostatistics, School of Public Health, Anhui Medical University, 81 Meishan Road, 230032 Hefei, Anhui, China.
Zhenhua
Z
Duan
Faming
F
Pan
Zhen
Z
Zeng
Tianchen
T
Zhang
Sheng
S
Wang
Guixing
G
Li
Shengqian
S
Xu
Jianhua
J
Xu
Li
L
Zhang
D005787:Gene Frequency; D020022:Genetic Predisposition to Disease; D006801:Humans; D016017:Odds Ratio; D010641:Phenotype; D020641:Polymorphism, Single Nucleotide; D018123:Receptors, Interleukin / Q000235:genetics*; D018570:Risk Assessment; D012307:Risk Factors; D013167:Spondylitis, Ankylosing / Q000235:genetics* / Q000276:immunology / Q000517:prevention & control
C515500:IL23R protein, human; D018123:Receptors, Interleukin
Nat Genet. 2010 Feb;42(2):123-7
20062062
Joint Bone Spine. 2009 Dec;76(6):623-8
19541528
Ann Rheum Dis. 2000 Nov;59(11):883-6
11053066
J Rheumatol. 2009 May;36(5):1003-5
19369463
Science. 2006 Dec 1;314(5804):1461-3
17068223
Nat Rev Immunol. 2005 Jul;5(7):521-31
15999093
Rheumatol Int. 2003 Mar;23(2):61-6
12634937
Rheumatology (Oxford). 2009 Apr;48(4):386-9
19189980
Rheumatol Int. 2009 Sep;29(11):1343-7
19247658
Nat Genet. 2007 Nov;39(11):1329-37
17952073
Arthritis Rheum. 2008 Apr;58(4):1020-5
18383363
Lancet. 2007 Apr 21;369(9570):1379-1390
17448825
Arthritis Rheum. 1997 Oct;40(10):1823-8
9336417
Rheumatol Int. 2010 May;30(7):955-9
19690863
Arthritis Res Ther. 2008;10(1):R17
18237382
Clin Exp Rheumatol. 2009 Sep-Oct;27(5):800-6
19917163
Ann Rheum Dis. 2008 Oct;67(10):1451-4
18199597
Trends Immunol. 2006 Jan;27(1):17-23
16290228
Scand J Immunol. 2009 Jul;70(1):68-74
19522770
BMC Med Genet. 2009 Jan 28;10:8
19175939
Arthritis Rheum. 1998 Jan;41(1):58-67
9433870
J Immunol. 2002 Jun 1;168(11):5699-708
12023369
Arthritis Rheum. 2009 Nov;60(11):3263-8
19877036
Dig Dis Sci. 2010 Jul;55(7):1818-23
19777350